Evaluation of Amino Acid Metabolism Changes in Ovarian Cancer - Trial NCT06216496
Access comprehensive clinical trial information for NCT06216496 through Pure Global AI's free database. This phase not specified trial is sponsored by University Hospital, Grenoble and is currently Not yet recruiting. The study focuses on Ovarian Cancer. Target enrollment is 23 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Sponsor & Location
University Hospital, Grenoble
Timeline & Enrollment
N/A
Jan 01, 2024
Dec 01, 2026
Primary Outcome
metabolism of each amino acid, in women with non-immediately resectable ovarian cancer (with or without peritoneal metastases) of high-grade serous type.
Summary
Ovarian cancer is associated with undernutrition in more than half of all cases. The current
 management of undernutrition-cachexia in cancer is not specific. It is well recognized that
 the nutritional support currently offered to cancer patients is not effective in combating
 cachexia, which progresses inexorably, leading to the patient's death. It is therefore
 necessary to offer specific and adapted care, in particular by optimizing the quality of
 nitrogen intake. To achieve this, the investigators first need to define the specific amino
 acid requirements of cancer patients.
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT06216496
Non-Device Trial